Ursula Rauch (Ursula Rauch-Kröhnert)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Insulin Resistance

Antiplatelet Therapy

Cardiovascular Disease

Pulmonary Embolism

Top Venues

Cardiovascular drugs and therapy

European heart journal

Cardiovascular diabetology

This page only lists publications with an associated author ORCID identifier.

Publications

Kai Jakobs, Ursula Rauch
Galectin-3 inhibitors as novel antithrombotic drugs with almost no bleeding risk: wishful thinking or a realistic vision? European heart journal 43 (37) (2022)
Marianna Puccini, Christian Rauch, Kai Jakobs, Julian Friebel, Adel Hassanein, Ulf Landmesser, Ursula Rauch
Being Overweight or Obese Is Associated with an Increased Platelet Reactivity Despite Dual Antiplatelet Therapy with Aspirin and Clopidogrel. Cardiovascular drugs and therapy (2022)
Javed Butler, Gerasimos S Filippatos, Tariq Jamal Siddiqi, Joao Pedro Ferreira, Martina Brueckmann, Edimar Alcides Bocchi, Michael Böhm, Vijay K Chopra, Nadia Giannetti, Tomoko Iwata, James L Januzzi, Sanjay Kaul, Iliana L Piña, Piotr Ponikowski, Ursula Rauch, Sanjiv J Shah, Michele Senni, Mikhail Sumin, Subodh Verma, Jian Zhang, Stuart J Pocock, Faiez Zannad, Milton Packer, Stefan D Anker
Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction. Circulation 146 (14) (2022)
Marco Witkowski, Mario Witkowski, Mona Saffarzadeh, Julian Friebel, Termeh Tabaraie, Loc Ta Bao, Aritra Chakraborty, Andrea Dörner, Bernd Stratmann, Diethelm Tschoepe, Samantha J Winter, Andreas Krueger, Wolfram Ruf, Ulf Landmesser, Ursula Rauch
Vascular miR-181b controls tissue factor-dependent thrombogenicity and inflammation in type 2 diabetes. Cardiovascular diabetology 19 (1) (2020)
Marco Witkowski, Julian Friebel, Termeh Tabaraie, Sinah Grabitz, Andrea Dörner, Lena Taghipour, Kai Jakobs, Bernd Stratmann, Diethelm Tschoepe, Ulf Landmesser, Ursula Rauch
Metformin Is Associated with Reduced Tissue Factor Procoagulant Activity in Patients with Poorly Controlled Diabetes. Cardiovascular drugs and therapy 35 (4) (2020)